An inhibitor of ouabain-insensitive sodium/sodium exchange in erythrocytes has been isolated from leukemic promyelocytes. To explore the specific effects of this inhibitor, named inhibitin, sodium transport experiments were carried out in human erythrocytes. Inhibitin reduced ouabain-insensitive bidirectional sodium transport. It did not change net sodium fluxes, had no significant effect on rubidium influx, and did not inhibit sodiumpotassium-ATPase activity. The inhibitory effect of inhibitin was studied on sodium/sodium exchange and on sodium/lithium countertransport in 140 mM sodium and in sodium-free media. In the presence of sodium, inhibitin reduced sodium and lithium efflux to that observed in sodium-free medium. Inhibitin showed no reduction in sodium or lithium efflux when sodium was replaced by choline chloride or Mg2e. When inhibitin was combined with one or more of the other transport inhibitors (i.e., ouabain, furosemide, or bumetanide and amiloride), its inhibitable component remained distinct and it did not overlap with that of the other inhibitors. These studies show that inhibitin is a specific inhibitor of carrier-mediated sodium/sodium exchange and sodium/lithium countertransport processes in human erythrocytes.
Introduction
Transport inhibitors have long been used as probes to define and investigate components of sodium and potassium transport in erythrocytes. Digitalis glycosides represent the most extensively studied group of inhibitors and are known to inhibit specifically sodium-potassium-ATPase, which drives active sodium/ potassium countertransport (the sodium pump) (1, 2) . The glycoside-insensitive, passive transport of sodium has many components which, in the past, have been the subject of much controversy (3) (4) (5) (6) (7) . In 1966 Hoffman and Kregenow (3) introduced the term "Pump II" which they thought regulated that fraction ofpassive sodium transport which was inhibitable by ethacrynic acid in the presence of maximal inhibitory concentrations of ouabain. Lubowitz and Whittam (5) , supported by Dunn (6, 7) , argued that "Pump II" was actually carrier-mediated sodium exchange diffusion and did not contribute to net flux.
The chief source of confusion was the lack of a specific inhibitor of sodium/sodium exchange: while Hoffman and Kregenow (3) and later Dunn (6, 7) thought that this process was inhibited by diuretics (ethacrynic acid and furosemide), Wiley and Cooper (8) showed that furosemide inhibited an ouabainAddress reprint requests to Dr. Mir. Receivedfor publication 21 March 1985 and in revisedform 8 October 1985. resistant sodium/potassium cotransport process. They concluded that the inhibitory action of furosemide was not explained by inhibition of exchange diffusion. It is now known that the diuretic-sensitive sodium/potassium/chloride cotransport system is distinct from sodium/sodium exchange (9) , but more recently Duhm (10) has proposed that the furosemide-sensitive transport system could also operate to achieve sodium/sodium exchange. Various investigators (1 1, 12) have also provided evidence that lithium is carried in the same transport system that mediates sodium/sodium exchange, and that this sodium/lithium countertransport is inhibited by phloretin (1 1) . It is now believed, however, that phloretin is a nonspecific inhibitor of carrier-mediated transport, and produces its effect by interfering with membrane structure (13) . In addition, our unpublished studies have shown that the effect of phloretin on sodium transport overlaps with that of other inhibitors (furosemide and ouabain). We have isolated a peptide, named inhibitin, from cultured leukemic promyelocytes which has shown various characteristics consistent with it being a sodium/sodium exchange inhibitor ( 14) . The purpose of this investigation was to explore the mechanism of action of inhibitin and use it in conjunction with other inhibitors to define its effect on sodium transport pathways in the human erythrocyte.
Methods

Reagents
All reagents were of Analar grade (BDH Chemicals, Ltd., Poole, Dorset, UK) and prepared in double-glass-distilled water. Na22, Rbl, and 
Isolation and purification ofinhibitin
This method has been described in detail previously (14) . Briefly, the supernatant obtained from sonicated cultured leukemic promyelocytes (HL60 cells) was subjected to gel-filtration on Sephadex G-25 Superfine (Pharmacia Fine Chemicals, Hounslow, Middlesex, UK). The peak of active material from this column was then chromatographed on DE-32 ion-exchange resin (Whatman, Maidstone, Kent, UK); the active bound material was eluted and run on a Sephadex G-10 column. Finally the active fraction was subjected to reverse-phase high-performance liquid chromatography (HPLC)' on a Hypersil ODS column (Jones Chromatography, Llanbradach, Mid Glam, UK). Biologically active material eluted in a single sharp peak which was used in the experiments outlined below.
Erythrocyte cation transport
Blood samples. Fresh human red cells were used in all experiments and drawn on the morning ofstudy by venipuncture into chilled heparinized (100 U/ml blood) syringes. As far as possible, blood samples were taken from the same normal healthy volunteers in order to minimize intersubject variation. Typical coefficients of variance for the total, active and passive components of erythrocyte sodium efflux from one subject were 3, 5, and 9%, respectively; these values are based on results obtained from three separate measurements over 6 mo.
Before use the blood was centrifuged (5,000 g) and the plasma and buffy coat were removed by aspiration. The cells were washed three times by repeated resuspension and centrifugation in Ringer's solution, which contained (millimolars): NaCl, 131; KCI, 8; MgSO4, 1; Na2HPO4, 7.2; NaH2PO4, 1.8; CaCI2, 2; glucose, 10; and bovine serum albumin, 0.05% wt/vol; pH 7.4 with an osmolality of 290±5 mosmol/kg water. The external potassium concentration was 8 mM to achieve optimal conditions for active sodium efflux. Leukocytes could be eliminated almost completely by removing the supernatant with the topmost layer ofcells after each wash. The final packed cell pellet was used immediately.
Sodium effiux. The methods for determining sodium transport in erythrocytes have been described fully elsewhere (15 described for the sodium efflux experiments. Choline chloride was used as a direct substitute for sodium chloride. Sodium/sodium exchange (i.e., external sodium-stimulated sodium effilux) was calculated as the difference in sodium efflux between the 140 mM sodium solution and the choline chloride solution.
Sodium-potassium-ATPase preparation (human elythrocytes). Erythrocyte vesicles were prepared by the method of Charalambous and Mir (18) ; this method yields high activities of total ATPase and sodium potassium-ATPase with a coefficient of variation of <8%. Protein concentration was determined by the method of Bradford (19) and ATPase activity by measurement of phosphate release (20) .
Ouabain radioreceptor assay. This method is based on that described by Erdmann (21) . The plasma and buffy coat were removed from a heparinized blood sample and the erythrocytes were washed three times with Ringer's solution (minus KCI), pH Fibroblast sodium transport. Ouabain-insensitive sodium efflux was determined following the procedure of Spurlock et al. (22) . Fibroblasts, obtained from skin biopsies of healthy volunteers, were cultured for 4 wk (medium changed twice weekly) in Eagle's minimum essential medium containing 10% fetal calf serum, 100 U/ml penicillin, 100 ,g/ml streptomycin, 0.225% sodium bicarbonate, and 2 mM L-glutamine (all reagents were purchased from Flow Laboratories, Inc., Irvine, Scotland) at 370C in an atmosphere of 5% CO2 in air. The cells were seeded at S X 104 cells/ml in 5-ml-vol petri dishes and were used for transport experiments after 6 d (two medium changes) when they had reached confluence. The cells were washed twice with 5 ml Hank's balanced salt solution minus potassium that contained (millimolars): NaCl, 141; CaC12, 1 Effect ofinhibitin on erythrocyte potassium movements. Potassium influx experiments in ouabain-treated erythrocytes (0.1 mM) were conducted as outlined in Methods using Rb86 as a potassium tracer. The influx of Rbss was measured in the presence of furosemide (final concentration, 1 mM) and inhibitin (0.1 tM), both separately and in combination. The external potassium concentration was 8 mM. The results of these experiments are outlined in Table II . Inhibitin failed to show a significant reduction of potassium influx. Furosemide produced a highly significant (P < 0.001) inhibition in agreement with the observations of Wiley and Cooper (8) .
Effect of inhibitin on erythrocyte lithium/sodium countertransport. Since lithium is thought to be transported by the same carrier as sodium/sodium exchange (I 1, 12), we studied the effects of inhibitin on lithium/sodium countertransport by following the method ofCanessa et al. (17) . In the sodium medium (145 mM), lithium/sodium countertransport is maximal with other processes for passive lithium efflux also occurring, whereas Fig. 1 shows the results of experiments in which the two solutions also contained 0.1 sM inhibitin. 47% of the ouabain-insensitive lithium movement (difference between columns 1 and 3) can be attributed to lithium/sodium countertransport; this value is in agreement with previously published observations (11) . Inhibitin produced significant inhibition (46%; P < 0.02) oflithium efflux in the sodium medium (columns 1 and 2), reducing the value to that observed in the Mg2' medium, but had no significant effect on the processes for lithium efflux which occur in the Mg2" medium (columns 3 and 4). Addition of inhibitin, therefore, had the same effect as removal of sodium, i.e., complete inhibition of lithium/sodium countertransport. These results confirm that sodium/sodium exchange and lithium/sodium countertransport are one and the same process, which are capable of being blocked by inhibitin.
The interaction of inhibitin with other transport inhibitors. The concept that sodium/sodium exchange is a carrier-mediated transport process was tested in a series of experiments in which inhibitin, a specific inhibitor of this process, was used in combination with one or more ofthe other transport inhibitors. The results of these experiments, as depicted in Fig. 2 , clearly demonstrate that the inhibitin-sensitive portion of sodium transport (i.e., carrier-mediated sodium/sodium exchange diffusion) is distinct and does not overlap with the ouabain-sensitive (column 3, P < 0.001) or furosemide-sensitive (column 5, P < 0.001) sodium efflux components. change) will not proceed, but sodium leak will. Therefore, the difference in sodium efflux in the two solutions represents a measure of sodium/sodium exchange by means of external sodium-stimulated sodium efflux. Inhibitin (1 iM) was tested under these conditions and the results are summarized in Table   III . The sodium/sodium exchange component was equivalent to 0.53 mmol/liter per h (difference in sodium efflux between the 140 and 0 mM external sodium solutions). In the presence of inhibitin, sodium efflux decreased (73%, P < 0.01) to that observed in the choline chloride medium, the inhibitin-sensitive component being 0.52 mmol/liter per h. These results are in direct agreement with those from the lithium/sodium countertransport experiment (Fig. 1) where addition of inhibitin likewise reduced efflux to that observed in the absence ofexternal sodium.
In the choline chloride solution, inhibitin had no effect, indicating that it is specific for the sodium/sodium exchange carrier. Inhibitin was also tested on sodium efflux in solutions that contained varying amounts of external sodium. These results are depicted in Fig. 3 . Inhibitin continued to produce significant inhibition (P < 0.005) in the 100 and 50 mM sodium solutions, but the effects were not significant at lower levels of external sodium as the efflux due to exchange diminished. These results suggest that inhibitin binds to the carrier that conducts sodium/ sodium exchange.
Effect ofinhibitin on sodium-potassium-A TPase. Past studies have shown that intracellular sodium-stimulated, ouabain-insensitive, sodium efflux is not mediated through ATPase (7). However, the inhibitors used such as furosemide, ethacrynic acid, and analogues were not specific inhibitors of sodium/sodium exchange. The availability of a specific agent, inhibitin, once again raised the question whether there is any link between this transport system and sodium-potassium-ATPase. To address this question we studied the effect of inhibitin on sodium-potassium-ATPase from human erythrocytes and on ouabain binding to human red blood cells. Erythrocyte sodium-potassium-ATPase activity was 0.493±0.070 (n = 4) ,umol phosphate/ mg protein per h. This accounted for 63% of total erythrocyte ATPase activity. In the presence of 0.1 ,uM inhibitin, which had decreased ouabain-insensitive sodium transport, the value was 0.517±0.083 (n = 5). These results, together with those in Fig.  3 , show that inhibitin has no significant inhibitory effect on erythrocyte vesicle sodium-potassium-ATPase and that it does not displace [3H]ouabain from its binding site (Fig. 4) . The inhibitory effect of inhibitin was also tested on canine kidney sodium-potassium-ATPase using an NADH-linked assay (23), in which ATP hydrolysis was enzymatically linked to NADH oxidation, and no inhibition was demonstrable (results not shown). These results show that the inhibitory effect of inhibitin on sodium/sodium exchange is not mediated through sodium-potassium-ATPase.
Effect ofinhibitin onfibroblast sodium transport. While the erythrocyte is a very useful model for studying sodium transport pathways, it is atypical of most mammalian cells, as it is largely dependent on anaerobic metabolism. For this reason the effect of inhibitin has also been tested on normal human fibroblasts. All these experiments were performed in the presence of 1 mM ouabain since the inhibitory effect of inhibitin on erythrocyte sodium movements is not mediated through sodium-potassiumATPase. The procedure used has been shown to be a reproducible and reliable method of measuring sodium transport in cultured fibroblasts (22 
Discussion
The dual purpose of this study was to establish the precise locus of action of inhibitin on erythrocyte sodium movements and, that a specific inhibitor of sodium/sodium exchange must fulfill at least six requirements: (a) show equal inhibition of sodium influx and efflux; (b) the effect should decrease when external sodium is lowered; (c) have no effect on net sodium transport; (d) have no effect on potassium fluxes; (e) show no effect on sodium-potassium-ATPase; and (f) it should show inhibition in addition to that achieved with the inhibitors ofother processes. The results presented in this paper show that the inhibitory characteristics of inhibitin meet all six requirements. Inhibitin reduces both sodium efflux and influx by equivalent amounts and does not alter net transport of sodium (Table I) , it has no significant effect on potassium influx (Table II) , inhibition is not seen when external sodium is removed (Table III and Fig. 3) , it has no effect on sodium-potassium-ATPase, and its inhibitory effect is distinct and unaffected when combined with other inhibitors (Fig. 2) . The last characteristic suggests that no other inhibitor affects the transport system that is inhibited by inhibitin.
Although furosemide, and later phloretin, have both been credited to possess inhibitory activity on sodium/sodium exchange, neither had been shown to have a specific inhibitable component that did not overlap with, nor was influenced by, the effect of other inhibitors. This was partly resolved by the studies of Wiley and Cooper (8) , who demonstrated that furosemide inhibited a specific sodium/potassium cotransport process which was distinct from other pathways. Phloretin has been shown to inhibit sodium/lithium countertransport (1 1) and partially inhibit sodium/sodium exchange (24) . Our studies have shown that phloretin, in increasing concentrations, interferes with other transport pathways (unpublished data), which suggests than its effects are nonspecific and are probably achieved through a toxic effect on the membrane. Shefcyk et al. (13) Sodium/sodium and sodium/lithium exchanges are known to operate through the same carrier (1 1, 12 ). The present study shows that a specific inhibitor of sodium/sodium exchange also inhibits sodium/lithium countertransport. This suggests that both processes are indeed conducted through the same pathway. In this regard, the availability of inhibitin, as a specific inhibitor of sodium/sodium exchange, should make an important contribution in defining differing transport characteristics, e.g., the relationship between sodium/sodium and sodium/hydrogen exchange systems, and also in determining the sodium transport pathways which exist in various cell types.
